Drugs with Adjusted Coinsurance Amounts for the Quarter April 1-June 30, 2023

A March 15 fact sheet issued by CMS includes a list of the first set of Part B rebatable drugs that will be subject to the adjusted coinsurance amounts for the quarter April 1-June 30, 2023.

A list of these 27 drugs and biologicals follows:

HCPCS Code	Short Description	Inflation-Adjusted Coinsurance Percentage (%)*
J0287	Abelcet	19.180
J8655	Akynzeo	16.213
J7504	Atgam	17.830
J3145	Aveed	19.239
J0558	Bicillin C-R	18.921
J0561	Bicillin L-A	18.514
J1955	Carnitor	13.918
J0850	Cytogam	18.983
J9269	Elzonris	19.969
J0699	Fetroja	10.274
J1572	Flebogamma DIF	17.655
J9307	Folotyn	19.965
J1645	Fragmin	13.995
J0135	Humira	19.529
J2820	Leukine	19.648
J2265	Minocin	19.288
J0888	Mircera	17.614
J9268	Nipent	17.269
J9177	Padcev	19.470
J9061	Rybrevant	19.747
J2502	Signifor LAR	18.406
J2860	Sylvant	19.777
Q2053	Tecartus	19.958
J2792	Winrho SDF	19.882
J0775	Xiaflex	18.960
J3299	Xipere	18.969
Q2041	Yescarta	19.937

* Normally 20%

Medicare

Drug Prices